Inventor
CHAUX PASCAL
BE16 patents
⚠️ This page may combine multiple inventors who share the name “CHAUX PASCAL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUDWIG INST CANCER RES
12 patentsUS5965535AOct 12, 1999
Mage-3 peptides presented by HLA class II molecules
LUDWIG INST CANCER RES51 citations96
US6291430B1Sep 18, 2001
Mage-3 peptides presented by HLA class II molecules
LUDWIG INST CANCER RES48 citations94
US6426217B1Jul 30, 2002
MAGE-3 peptides presented by HLA class II molecules
LUDWIG INST CANCER RES17 citations91
US6531451B1Mar 11, 2003
Tumor antigens and CTL clones isolated by a novel procedure
LUDWIG INST CANCER RES24 citations89
US7049413B2May 23, 2006
MAGE-A3 peptides presented by HLA class II molecules
LUDWIG INST CANCER RES11 citations84
US6716809B1Apr 6, 2004
Mage-A3 peptides presented by HLA class molecules
LUDWIG INST CANCER RES15 citations82
US7388072B2Jun 17, 2008
MAGE peptides presented by HLA class II molecules
LUDWIG INST CANCER RES5 citations74
US6369211B1Apr 9, 2002
MAGE-3 peptides presented by HLA class II molecules
LUDWIG INST CANCER RES10 citations73
US6710172B1Mar 23, 2004
Tumor antigens and CTL clones isolated by a novel procedure
LUDWIG INST CANCER RES7 citations70
US7371845B2May 13, 2008
MAGE-A3 peptides presented by HLA class II molecules
LUDWIG INST CANCER RES2 citations62
US7157091B1Jan 2, 2007
MAGE-A1 peptides presented by HLA class II molecules
LUDWIG INST CANCER RES4 citations62
US7351409B2Apr 1, 2008
Tumor antigens and CTL clones isolated by a novel procedure
LUDWIG INST CANCER RES3 citations59